Mounjaro Tirzepatide 12.5mg KwikPen for Diabetes & Weight Management 4 Doses

Mounjaro 12.5mg KwikPen contains Tirzepatide, a prescription once-weekly injection for adults with type 2 diabetes.

It also supports chronic weight management in suitable adults alongside a healthy diet and regular physical activity.

• Contains Tirzepatide 12.5mg for blood sugar and weight support

• Once-weekly subcutaneous injection prescribed for adults

• KwikPen provides four weekly doses per pen

• Helps improve blood sugar control in type 2 diabetes

• Supports appetite control and healthy weight reduction

• Dual GIP and GLP-1 receptor agonist

Benefits:

• Helps manage blood sugar levels

• Supports healthy weight management

• Helps reduce appetite

• Supports a full month of weekly doses per pen

• Helps improve glycemic control

• Promotes easy self-injection at home

• Assists treatment alongside diet and exercise

How to Use:

• Use only as prescribed by your doctor.

• Inject 12.5mg once weekly using the KwikPen.

• Inject under the skin.

• Rotate injection sites.

• Use on the same day each week.

• Follow your prescribed dose schedule.